JNJ
Johnson & Johnson
USNYSE: JNJ
JNJ
Johnson & Johnson
USNYSE: JNJ
Healthcare
Drug Manufacturers - GeneralUS

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

$146.43

0%
$0
Grades
A
Exceptional profitability with great dividend
Excellent quality, with strong balance sheet and profitability. A fantastic company.
Acceptable dividend and business growth with some warning signs.
The stock doesn't seem undervalued or overvalued. More valuation analysis is required.
Market Cap
$353B
Mega-Cap
EPS (TTM)
$6.10
Dividend Yield
3.19%
Great Yield
Dividend Streak
61 years
Since 1963
Payout Ratio
81.3%
High Payout
Dividend Growth
5.8%
CAGR - 5Y
Revenue/ share$36.43
FCF/ share$8.10
Earnings Yield4.17%
Gross Margin69.05%
Operating Margin25.22%
ROE20.94%
Cash$20.0B
Net Debt$15.8B
Debt to Equity0.51
PE24.00
EV/Sales4.20
Beta0.52